Improving access to Early Intervention in Psychosis (EIP): the 2-week wait for cancer comes to psychosis

BMJ Open Quality
Kirit SinghPeter Carter

Abstract

Early Intervention in Psychosis (EIP) services aim to rapidly initiate specialist packages of care for those people newly experiencing symptoms. The intention of such rapid engagement is to mitigate the negative effects of a prolonged duration of untreated psychosis. Aiming to achieve a 'parity of esteem' between mental and physical health, a new target was introduced by the National Health Service (NHS) England, where 50% of new referrals were expected to receive a concordant package of care within 2 weeks from the National Institute for Health and Care Excellence. A baseline assessment in late 2014 found that just 21% of all referrals received and accepted met this target within the EIP Team for the North-East London NHS Foundation Trust. This project sought to improve the team's performance, seeking input from all team members and using an iterative process with the primary aim of meeting the target ahead of its roll-out. It was determined that the relatively high number of inappropriate referrals (34% at baseline) is a key causative agent in delaying staff from processing eligible cases in a timely fashion. These are defined as referrals which do not meet basic eligibility criteria such as no previous treatment for psychosi...Continue Reading

References

Dec 15, 2000·Public Health·R Slack
Feb 24, 2001·Social Psychiatry and Psychiatric Epidemiology·H J Jackson, P M Burgess
Jun 11, 2003·Archives of General Psychiatry·Andre AlemanJean-Paul Selten
Dec 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Swaran P SinghGlynn Harrison
May 2, 2006·The American Journal of Psychiatry·Ingrid MelleThomas McGlashan
May 8, 2010·Schizophrenia Research·Silke BachmannAndré Rupp
Sep 15, 2010·Indian Journal of Psychiatry·Amresh ShrivastavaGurusamy Chinnasamy
Sep 13, 2011·Schizophrenia Bulletin·Max Marshall, John Rathbone
Sep 12, 2012·Schizophrenia Research and Treatment·Susana OchoaJayashri Kulkarni
Sep 26, 2012·Social Psychiatry and Psychiatric Epidemiology·Crick LundAlan J Flisher
Nov 14, 2012·Evidence-based Mental Health·Chris Naylor
May 25, 2013·The British Journal of Psychiatry : the Journal of Mental Science·Max BirchwoodSwaran P Singh
Sep 25, 2014·The British Journal of Psychiatry : the Journal of Mental Science·Matti PenttiläJouko Miettunen
Feb 28, 2015·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Francisco Leyva, Christopher J Plummer
Apr 2, 2016·BMJ : British Medical Journal·Michael McCarthy
Jun 3, 2016·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Marie NolinAmal Abdel-Baki
Jul 21, 2016·BMJ : British Medical Journal·Anne Gulland

❮ Previous
Next ❯

Software Mentioned

ACCESS

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here